NIOX Group PLC CSSPF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.77
- Day Range
- $0.75–0.75
- 52-Week Range
- $0.48–0.77
- Bid/Ask
- $0.00 / $5.45
- Market Cap
- $315.53 Mil
- Volume/Avg
- 19,000 / 19,000
Key Statistics
- Price/Earnings (Normalized)
- 24.88
- Price/Sales
- 7.37
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- 1.67%
- Total Yield
- 0.03%
Company Profile
NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 92
- Website
- https://www.niox.com
Comparables
Valuation
|
Metric
|
CSSPF
|
DWF
|
SWAV
|
|---|---|---|---|
Price/Earnings (Normalized) | 24.88 | 8.98 | 85.13 |
Price/Book Value | 3.73 | 7.24 | 16.51 |
Price/Sales | 7.37 | 0.85 | 16.10 |
Price/Cash Flow | 22.22 | 6.01 | 51.95 |
Price/Earnings
CSSPF
DWF
SWAV
Financial Strength
|
Metric
|
CSSPF
|
DWF
|
SWAV
|
|---|---|---|---|
Quick Ratio | 3.99 | 1.78 | 12.49 |
Current Ratio | 4.65 | 1.93 | 13.81 |
Interest Coverage | 34.00 | 3.39 | 19.59 |
Quick Ratio
CSSPF
DWF
SWAV
Profitability
|
Metric
|
CSSPF
|
DWF
|
SWAV
|
|---|---|---|---|
Return on Assets (Normalized) | 18.37% | 9.44% | 18.92% |
Return on Equity (Normalized) | 24.61% | 73.80% | 36.87% |
Return on Invested Capital (Normalized) | 20.31% | 15.38% | 20.45% |
Return on Assets
CSSPF
DWF
SWAV
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Xpwlvczxh | Fmmtr | $182.4 Bil | |
SYK
| Stryker Corp | Yrmxqwwd | Mpnt | $126.5 Bil | |
MDT
| Medtronic PLC | Nzfdqbfx | Kcsqgm | $111.9 Bil | |
BSX
| Boston Scientific Corp | Fdbgyvcz | Clhdwwt | $108.0 Bil | |
EW
| Edwards Lifesciences Corp | Rvmngvnf | Tglmsf | $54.3 Bil | |
DXCM
| DexCom Inc | Dxtdtdsyt | Nzll | $52.2 Bil | |
PHG
| Koninklijke Philips NV ADR | Vslrbcv | Mbpdp | $25.6 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Dlgzmlrxw | Kxjh | $24.9 Bil | |
ALGN
| Align Technology Inc | Chfqgjr | Dkjcnf | $20.6 Bil | |
PODD
| Insulet Corp | Rrdmxntk | Wjtkq | $11.3 Bil |